SYK
Stryker·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 2
Consensus Rating "Buy"
Ample Liquidity
High Gross Profit Margin
Revenue Beats Expectation
Bearish Abandoned Baby
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SYK
Stryker Corporation
One of the world's leading medical technology companies that offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine
Healthcare Equipment and Supplies
--
07/24/1997
New York Stock Exchange
53,000
12-31
Common stock
1941 Stryker Way, Portage, Michigan 49002
Innovative products and services in orthopedics, medical and surgical, and neurotechnology and spine
Stryker Corporation was incorporated in Michigan in 1946 as part of a business founded by Dr. Homer in 1941. The company is one of the world's leading medical technology companies, working with customers to make healthcare better. The company provides innovative products and services in orthopedics, medical and surgical, neurotechnology and spine to help improve patient and hospital outcomes.
Earnings Call
Company Financials
EPS
SYK has released its 2025 Q3 earnings. EPS was reported at 3.19, versus the expected 3.13, beating expectations. The chart below visualizes how SYK has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SYK has released its 2025 Q3 earnings report, with revenue of 6.06B, reflecting a YoY change of 10.25%, and net profit of 859.00M, showing a YoY change of 3.00%. The Sankey diagram below clearly presents SYK's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


